14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of KROS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Keros Therapeutics Inc. stock price down 3.65% on Thursday
(Updated on Apr 25, 2024)

Sell candidate since Apr 23, 2024 Loss -1.81% PDF

The Keros Therapeutics Inc. stock price fell by -3.65% on the last day (Thursday, 25th Apr 2024) from $56.24 to $54.19. During the last trading day the stock fluctuated 3.40% from a day low at $53.24 to a day high of $55.05. The price has fallen in 7 of the last 10 days and is down by -12.46% for this period. Volume has increased on the last day by 787 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 253 thousand shares were bought and sold for approximately $13.72 million.

Given the current short-term trend, the stock is expected to rise 5.33% during the next 3 months and, with a 90% probability hold a price between $57.08 and $76.29 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

KROS Signals & Forecast

There are few to no technical positive signals at the moment. The Keros Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $56.84 and $63.09. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 08, 2024, and so far it has fallen -23.11%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Keros Therapeutics Inc. stock

Keros Therapeutics Inc. finds support from accumulated volume at $53.59 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.81 between high and low, or 3.40%. For the last week, the stock has had daily average volatility of 5.43%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (KROS) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Keros Therapeutics Inc. to open at $54.16, and during the day (based on 14 day Average True Range), to move between $50.96 and $57.42, which gives a possible trading interval of +/-$3.23 (+/-5.95%) up or down from last closing price. If Keros Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 11.91% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $53.59 (1.11%) than the resistance at $57.35 (5.83%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Keros Therapeutics Inc. will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$1.31. We will update the financials statements for Keros Therapeutics Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 8.45% in the first trading day after earnings release.

Is Keros Therapeutics Inc. stock A Buy?

The Keros Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Keros Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.555 Sell Candidate Unchanged

Predicted Opening Price for Keros Therapeutics Inc. of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$54.16 ( 0.0554%) $54.19

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for KROS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 55.97 3.28 %
R2 55.28 2.01 %
R1 54.85 1.22 %
Current price: 54.19
Support S1 53.47 -1.33 %
S2 53.04 -2.12 %
S3 52.35 -3.40 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 67.35 24.28 %
R2 64.66 19.32 %
R1 57.35 5.83 %
Current price 54.19
Support S1 53.59 -1.11%
S2 53.02 -2.16%
S3 52.27 -3.54%

FAQ

What is the symbol for Keros Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Keros Therapeutics Inc. is KROS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Keros Therapeutics Inc. Stock?
The Keros Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Keros Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Keros Therapeutics Inc. Stock?
Keros Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Keros Therapeutics Inc. Stock.

What's the current price of Keros Therapeutics Inc. Stock?
As of the end of day on the Apr 25, 2024, the price of an Keros Therapeutics Inc. (KROS) share was $54.19.

What is the 52-week high and low for Keros Therapeutics Inc. Stock?
The 52-week high for Keros Therapeutics Inc. Stock is $73.00 and the 52-week low is $27.03.

What is the market capitalization of Keros Therapeutics Inc. Stock?
As of the Apr 25, 2024, the market capitalization of Keros Therapeutics Inc. is 1.95B.

When is the next earnings date for Keros Therapeutics Inc.?
The upcoming earnings date for Keros Therapeutics Inc. is May 02, 2024.
Click to get the best stock tips daily for free!

About Keros Therapeutics Inc.

Keros Therapeutics. Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in pat... KROS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT